ATE318605T1 - Triphasisches, orales kontrazeptivum - Google Patents

Triphasisches, orales kontrazeptivum

Info

Publication number
ATE318605T1
ATE318605T1 AT99963049T AT99963049T ATE318605T1 AT E318605 T1 ATE318605 T1 AT E318605T1 AT 99963049 T AT99963049 T AT 99963049T AT 99963049 T AT99963049 T AT 99963049T AT E318605 T1 ATE318605 T1 AT E318605T1
Authority
AT
Austria
Prior art keywords
oral contraceptive
triphasic oral
triphasic
contraceptive
oral
Prior art date
Application number
AT99963049T
Other languages
English (en)
Inventor
Gary Shangold
Arkady Rubin
David Upmalis
Original Assignee
Ortho Mcneil Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22349144&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE318605(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ortho Mcneil Pharm Inc filed Critical Ortho Mcneil Pharm Inc
Application granted granted Critical
Publication of ATE318605T1 publication Critical patent/ATE318605T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT99963049T 1998-12-23 1999-12-08 Triphasisches, orales kontrazeptivum ATE318605T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11339498P 1998-12-23 1998-12-23

Publications (1)

Publication Number Publication Date
ATE318605T1 true ATE318605T1 (de) 2006-03-15

Family

ID=22349144

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99963049T ATE318605T1 (de) 1998-12-23 1999-12-08 Triphasisches, orales kontrazeptivum

Country Status (26)

Country Link
US (2) US6214815B1 (de)
EP (1) EP1140109B1 (de)
JP (1) JP2002533398A (de)
KR (1) KR100669165B1 (de)
CN (1) CN100408040C (de)
AR (1) AR028809A1 (de)
AT (1) ATE318605T1 (de)
AU (1) AU765153B2 (de)
BR (1) BR9916579A (de)
CA (1) CA2356747C (de)
CY (1) CY1105276T1 (de)
CZ (1) CZ302568B6 (de)
DE (1) DE69930157T2 (de)
DK (1) DK1140109T3 (de)
ES (1) ES2259481T3 (de)
HU (1) HU229251B1 (de)
MX (1) MXPA01006533A (de)
NO (1) NO321118B1 (de)
NZ (1) NZ512404A (de)
PL (1) PL196715B1 (de)
PT (1) PT1140109E (de)
RU (1) RU2225207C2 (de)
SK (1) SK287931B6 (de)
TR (1) TR200101826T2 (de)
WO (1) WO2000038691A1 (de)
ZA (1) ZA200106006B (de)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5898032A (en) 1997-06-23 1999-04-27 Medical College Of Hampton Roads Ultra low dose oral contraceptives with less menstrual bleeding and sustained efficacy
HUP9900213A1 (hu) * 1999-02-01 2000-12-28 Gábor Bogye Gyógykompozíció(k) gesztagén tipusú hormon tartalmú gyógyszerek thromb-embóliás mellékhatásainak mérséklésére
US20060281723A1 (en) * 1999-04-16 2006-12-14 Kafrissen Michael E Folic acid-containing pharmaceutical compositions, and related methods and delivery systems
DK1390040T3 (da) * 2001-05-18 2007-04-23 Pantarhei Bioscience Bv Farmaceutisk præparat til anvendelse i hormonerstatningsterapi
EP1260225A1 (de) * 2001-05-18 2002-11-27 Pantarhei Bioscience B.V. Pharmazeutische Zusammensetzung für die Hormonersatztherapie
EP1390042B1 (de) * 2001-05-23 2007-11-28 Pantarhei Bioscience B.V. Tetrahydroxylierte estrogen enthaltendes arzneistoffverabreichungssystem zur verwendung in hormonalen kontrazeption
EP1390043A1 (de) * 2001-05-23 2004-02-25 Pantarhei Bioscience B.V. Mittel und verfahren zur hormonalen kontrazeption
US7871995B2 (en) * 2001-05-23 2011-01-18 Pantarhei Bioscience B.V. Drug delivery system comprising a tetrahydroxylated estrogen for use in hormonal contraception
DE60216630T2 (de) * 2001-11-15 2007-09-20 Pantarhei Bioscience B.V. Verwendung von östrogen in kombination mit progestogen für die hormonsubstitutiionstherapie
NZ591627A (en) 2001-12-05 2012-09-28 Teva Womens Health Inc Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology
CA2489271C (en) * 2002-06-11 2011-12-06 Pantarhei Bioscience B.V. Method of treating or preventing immune mediated disorders and pharmaceutical formulation for use therein
AU2003274941A1 (en) * 2002-06-11 2003-12-22 Pantarhei Bioscience B.V. A method of treating human skin and a skin care composition for use in such a method
US9034854B2 (en) * 2002-07-12 2015-05-19 Pantarhei Bioscience B.V. Pharmaceutical composition comprising estetrol derivatives for use in cancer therapy
JP2004140323A (ja) * 2002-08-20 2004-05-13 Sharp Corp 半導体レーザ装置およびその製造方法
AU2003274823A1 (en) * 2002-10-23 2004-05-13 Pantarhei Bioscience B.V. Pharmaceutical compositions comprising estetrol derivatives for use in cancer therapy
EP1624848A4 (de) 2003-05-02 2009-02-25 Duramed Pharmaceuticals Inc Verfahren zur hormonbehandlung mit kontrazeptva-schemata mit verlängertem zyklus
NZ545130A (en) * 2003-07-16 2009-03-31 Duramed Pharmaceuticals Inc Methods of hormonal treatment utilizing contraceptive regimens with continuous estrogen administration
WO2005032558A1 (en) * 2003-10-01 2005-04-14 Janssen Pharmaceutica N.V. Extended triphasic contraceptive regimens
DE102004026671A1 (de) * 2004-05-28 2005-12-15 Grünenthal GmbH Darreichungsform zur hormonalen Kontrazeption
US20070111975A1 (en) * 2004-10-07 2007-05-17 Duramed Pharmaceuticals, Inc. Methods of Hormonal Treatment Utilizing Ascending-Dose Extended Cycle Regimens
MX2007004120A (es) * 2004-10-07 2007-06-15 Duramed Pharmaceuticals Inc Metodos de tratamiento hormonal utilizando regimentes de ciclo prolongado de dosis ascendente.
US20070077269A1 (en) * 2005-10-04 2007-04-05 Woodward John R Method of birth control and hormone regulation
US20070254025A1 (en) * 2006-04-27 2007-11-01 Cronk Peter J Oral contraceptive and acne medication combination and treatment of acne with reduced side effects
US20070254858A1 (en) * 2006-04-27 2007-11-01 Cronk Peter J Contraceptive and Acne Medication Combination and Treatment of Acne and Other Diseases with Reduced Side Effects
CN101489563A (zh) * 2006-07-06 2009-07-22 拜耳先灵医药股份有限公司 用于避孕和预防先天性畸形风险的药物制剂
CN101583363B (zh) * 2007-01-08 2013-08-21 潘塔希生物科学股份有限公司 治疗或预防雌性哺乳动物不育症的方法和此类方法中使用的药物试剂盒
DE102007011486A1 (de) * 2007-03-07 2008-09-11 Grünenthal GmbH Arzneimittel umfassend wenigstens ein Gestagen
US20100178323A1 (en) 2007-07-10 2010-07-15 Agis Kydonieus Dermal Delivery Device
WO2010042607A1 (en) 2008-10-08 2010-04-15 Agile Therapeutics, Inc Transdermal delivery
WO2010042612A1 (en) 2008-10-08 2010-04-15 Agile Therapeutics, Inc. Transdermal delivery
WO2010042610A1 (en) 2008-10-08 2010-04-15 Agile Therapeutics, Inc. Transdermal delivery
EP2410859A4 (de) 2009-03-27 2013-03-13 Agile Therapeutics Inc Transdermale freisetzung
US8951996B2 (en) 2011-07-28 2015-02-10 Lipocine Inc. 17-hydroxyprogesterone ester-containing oral compositions and related methods
CN107847506A (zh) 2015-06-22 2018-03-27 来普卡公司 含17‑羟基孕酮酯的口服组合物和相关方法

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3568828A (en) 1967-03-01 1971-03-09 Squibb & Sons Inc Modified sequential oral contraceptive
US3836651A (en) 1972-02-22 1974-09-17 Biolog Concepts Inc Novel oral contraceptive combination
DE2310963A1 (de) 1972-04-14 1974-09-05 Schering Ag Methode zur kontrazeption durch verabfolgung von stufenkombinationspraeparaten
US3969502A (en) 1972-04-14 1976-07-13 Schering Aktiengesellschaft Method for contraception by the administration of sequential contraceptive preparations
US3932635A (en) 1972-04-24 1976-01-13 Syntex Corporation Novel cyclic progestogen-interrupted estrogen oral contraceptive regimens
DE2365103C3 (de) 1973-12-21 1980-08-28 Schering Ag, 1000 Berlin Und 4619 Bergkamen V erwendung von Hormonen zur Kontrazeption
US4291028A (en) 1977-12-30 1981-09-22 Nichols Vorys Follicular phase estrogen or progestin with physiologic estrogen/progestin luteal phase replacement drug delivery system
NL8001593A (nl) 1980-03-18 1981-10-16 Akzo Nv Meerfasisch combinatiepreparaat voor orale anticonceptie.
US4390531A (en) 1981-08-10 1983-06-28 Syntex Pharmaceuticals International Ltd. Method of contraception using peak progestogen dosage
USRE35724E (en) 1982-04-28 1998-02-03 Bio-Technology General Corp. Contraception system and method
US4921843A (en) 1988-10-20 1990-05-01 Pasquale Samuel A Contraception system and method
US4616006A (en) 1983-09-26 1986-10-07 Ortho Pharmaceutical Corporation Triphasic oral contraceptive
US4544554A (en) 1983-09-26 1985-10-01 Ortho Pharmaceutical Corporation Triphasic oral contraceptive
US4628051A (en) 1983-09-26 1986-12-09 Ortho Pharmaceutical Corporation Triphasic oral contraceptive
US4530839A (en) 1983-09-26 1985-07-23 Ortho Pharmaceutical Corporation Triphasic oral contraceptive
US4962098A (en) 1987-06-15 1990-10-09 Warner-Lambert Company Graduated estrogen contraceptive
US5023084A (en) 1986-12-29 1991-06-11 Rutgers, The State University Of New Jersey Transdermal estrogen/progestin dosage unit, system and process
US5276022A (en) 1987-09-24 1994-01-04 Jencap Research Ltd. Hormone preparation and method
US4948593A (en) 1989-05-15 1990-08-14 Alza Corporation Osmotic dosage form comprising an estrogen and a progestogen
IE71203B1 (en) 1990-12-13 1997-02-12 Akzo Nv Low estrogen oral contraceptives
IE62665B1 (en) * 1990-12-17 1995-02-22 Akzo Nv Contraceptive regimen
US5453279A (en) 1992-04-21 1995-09-26 Tbs Laboratories, Inc. Enhancing transdermal absorption compositions; transdermal dosage form; and process
US5759577A (en) * 1995-01-17 1998-06-02 American Home Products Corporation Controlled release of steroids from sugar coatings
DE19513662A1 (de) * 1995-04-08 1996-10-10 Schering Ag Pharmazeutisches Kombinationspräparat zur hormonalen Kontrazeption
DE19525017A1 (de) * 1995-06-28 1997-01-02 Schering Ag Pharmazeutisches Kombinatonspräparat, Kit und Methode zur hormonalen Kontrazeption
US5747480A (en) 1996-05-08 1998-05-05 American Home Products Corporation Oral contraceptive

Also Published As

Publication number Publication date
CA2356747C (en) 2005-09-27
MXPA01006533A (es) 2002-06-04
EP1140109A1 (de) 2001-10-10
SK287931B6 (sk) 2012-04-03
HUP0104680A3 (en) 2002-06-28
DE69930157D1 (de) 2006-04-27
BR9916579A (pt) 2001-10-02
SK8872001A3 (en) 2002-03-05
PT1140109E (pt) 2006-05-31
US20010044429A1 (en) 2001-11-22
ES2259481T3 (es) 2006-10-01
CA2356747A1 (en) 2000-07-06
AU765153B2 (en) 2003-09-11
WO2000038691A1 (en) 2000-07-06
NO20013144L (no) 2001-08-23
NZ512404A (en) 2003-08-29
HU229251B1 (en) 2013-10-28
CY1105276T1 (el) 2010-03-03
CZ302568B6 (cs) 2011-07-13
US6214815B1 (en) 2001-04-10
AU1936500A (en) 2000-07-31
KR20010081087A (ko) 2001-08-25
DK1140109T3 (da) 2006-05-15
CN100408040C (zh) 2008-08-06
RU2225207C2 (ru) 2004-03-10
HUP0104680A2 (hu) 2002-04-29
PL196715B1 (pl) 2008-01-31
TR200101826T2 (tr) 2001-12-21
DE69930157T2 (de) 2006-08-31
JP2002533398A (ja) 2002-10-08
NO20013144D0 (no) 2001-06-22
CZ20012184A3 (cs) 2003-01-15
ZA200106006B (en) 2002-10-21
AR028809A1 (es) 2003-05-28
KR100669165B1 (ko) 2007-01-17
EP1140109B1 (de) 2006-03-01
CN1334734A (zh) 2002-02-06
NO321118B1 (no) 2006-03-20

Similar Documents

Publication Publication Date Title
ATE318605T1 (de) Triphasisches, orales kontrazeptivum
TR199901077A3 (tr) Ispençiyari formülasyonlar.
ID26720A (id) Komposisi oral
DE69827672D1 (de) Teleskopartiges intraorales kraftelement
IS5555A (is) Selekoxib lyfjablöndur
ID30031A (id) Formulasi-formulasi agrokimia
ID23546A (id) Formulasi-formulasi ziprasidon
ID29241A (id) Turunan-turunan kinolin teranelasi-1,2
NO20004240L (no) Formuleringer
ATE224703T1 (de) Brauseformulierungen
DE59900501D1 (de) Feste, schnellzerfallende cetirizin-formulierungen
PT1130966E (pt) Formulacoes antiparasitarias
DE69910462D1 (de) Cervicalorthese
DE69822598D1 (de) Zigarettenschachtel
DE60007530D1 (de) Oral wirksame androgene
IS4947A (is) Tróvafloxasín mesýlat tafla
ATE309838T1 (de) Pharmazeutisches implantat
ID26909A (id) Turunan-turunan 1,3,4-oksadiazolon
ATE234839T1 (de) 4,5-azolo-oxindole
IT1304443B1 (it) Dispositivo formatore di gruppi di sigarette.
EP1074250A4 (de) Zuckerbeschichtete tabletten
DZ2917A1 (fr) Nouveau 3-tetrahydropyridin-4-yl indoles.
ITBO980332A0 (it) Dispositivo di controllo di pacchetti di sigarette.
DE59909590D1 (de) Azidfreie, gaserzeugende zusammensetzung
DE69814034D1 (de) Trichter

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1140109

Country of ref document: EP